NOVEL FORMULATIONS

A pharmaceutical aerosol formulation includes a therapeutically effective amount of particulate medicament of formula (I) or a solvate thereof, a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoro-n-propane or mixtures thereof, and a biocompatible p...

Full description

Saved in:
Bibliographic Details
Main Authors STEFELY, JAMES S, CAPECCHI, JOHN T
Format Patent
LanguageEnglish
French
Published 21.07.2011
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:A pharmaceutical aerosol formulation includes a therapeutically effective amount of particulate medicament of formula (I) or a solvate thereof, a propellant selected from the group consisting of 1,1,1,2-tetrafluoroethane, 1,1,1,2,3,3,3-heptafluoro-n-propane or mixtures thereof, and a biocompatible polymer comprising one or more compounds of formula (II) l'invention concerne une préparation pharmaceutique en aérosol comprenant une dose thérapeutique d'un médicament particulaire représenté par la formule (I) ou un solvate de ce médicament, un agent propulseur pris dans le groupe composé de 1,1,1,2-tétrafluoroéthane, de 1,1,1,2,3,3,3-heptafluoro-n-propane ou de mélanges de ces substances, et d'un polymmère biocompatible contenant un ou des composés de formule (II).
Bibliography:Application Number: WO2007US64512